Huperzine—A Improved Animal Behavior in Cuprizone-Induced Mouse Model by Alleviating Demyelination and Neuroinflammation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Huperzine—A Improved Animal Behavior in Cuprizone-Induced Mouse Model by Alleviating Demyelination and Neuroinflammation
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 24, Pages 16182
Publisher
MDPI AG
Online
2022-12-19
DOI
10.3390/ijms232416182
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination
- (2022) Martin Zirngibl et al. Molecular Neurodegeneration
- Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysis
- (2021) Samuel Klistorner et al. PLoS One
- Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis
- (2021) Ermelinda De Meo et al. JAMA Neurology
- Microglia and Central Nervous System–Associated Macrophages—From Origin to Disease Modulation
- (2021) Marco Prinz et al. Annual Review of Immunology
- Potential of Naturally Derived Alkaloids as Multi-Targeted Therapeutic Agents for Neurodegenerative Diseases
- (2021) Yew Rong Kong et al. MOLECULES
- The effects of Huperzine A on dementia and mild cognitive impairment: An overview of systematic reviews
- (2021) Nafiseh Ghassab‐Abdollahi et al. PHYTOTHERAPY RESEARCH
- Behavioral and neurobiological changes in a novel mouse model of schizophrenia induced by the combination of cuprizone and MK-801
- (2021) Zheng-yu Sun et al. BRAIN RESEARCH BULLETIN
- Myelin Biology
- (2021) Alessandra Bolino Neurotherapeutics
- A metabolic regulon reveals early and late acting enzymes in neuroactive Lycopodium alkaloid biosynthesis
- (2021) Ryan S. Nett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Huperzia serrata Extract ‘NSP01’ With Neuroprotective Effects-Potential Synergies of Huperzine A and Polyphenols
- (2021) N. Callizot et al. Frontiers in Pharmacology
- Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
- (2021) Alanna G. Spiteri et al. ACTA NEUROPATHOLOGICA
- Multiple sclerosis and myelin basic protein: insights into protein disorder and disease
- (2021) Vebjørn Martinsen et al. AMINO ACIDS
- The Immune Response in Multiple Sclerosis
- (2021) Sofía Rodríguez Murúa et al. Annual Review of Pathology-Mechanisms of Disease
- Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer’s Disease
- (2021) María Jesús Friedli et al. MOLECULES
- Valproic acid suppresses cuprizone-induced hippocampal demyelination and anxiety-like behavior by promoting cholesterol biosynthesis
- (2021) Xinjian Zhu et al. NEUROBIOLOGY OF DISEASE
- Cuprizone feed formulation influences the extent of demyelinating disease pathology
- (2021) Lillian M. Toomey et al. Scientific Reports
- Diosgenin ameliorates cellular and molecular changes in multiple sclerosis in C57BL/6 mice
- (2021) Hossein Zeinali et al. Multiple Sclerosis and Related Disorders
- Differential Expression of miRNAs and Behavioral Change in the Cuprizone-Induced Demyelination Mouse Model
- (2020) Han et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NEP1-40 alleviates behavioral phenotypes and promote oligodendrocyte progenitor cell differentiation in the hippocampus of cuprizone-induced demyelination mouse model
- (2020) Qiang Liu et al. NEUROSCIENCE LETTERS
- Dynamic Balance of Microglia and Astrocytes Involved in the Remyelinating Effect of Ginkgolide B
- (2020) Jun-Jun Yin et al. Frontiers in Cellular Neuroscience
- Cognitive Dysfunction in the Early Stages of Multiple Sclerosis—How Much and How Important?
- (2020) Magdalena Oset et al. Current Neurology and Neuroscience Reports
- Central and peripheral anti-inflammatory effects of acetylcholinesterase inhibitors
- (2020) Shani Vaknine et al. NEUROPHARMACOLOGY
- The Cuprizone Model: Dos and Do Nots
- (2020) Jiangshan Zhan et al. Cells
- Mitogen-activated protein kinases are involved in cucurbitacin D-induced antitumor effects on adult T-cell leukemia cells
- (2020) Duo Wang et al. INVESTIGATIONAL NEW DRUGS
- Depression and cognitive function in early multiple sclerosis: Multitasking is more sensitive than traditional assessments
- (2020) Lisa Glukhovsky et al. Multiple Sclerosis Journal
- Similar tests of anxiety-like behavior yield different results: comparison of the open field and free exploratory rodent procedures
- (2020) Christen N. Snyder et al. PHYSIOLOGY & BEHAVIOR
- Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases
- (2019) Jose M. Vega-Riquer et al. Current Neuropharmacology
- Donepezil, a drug for Alzheimer’s disease, promotes oligodendrocyte generation and remyelination
- (2019) Xue Cui et al. ACTA PHARMACOLOGICA SINICA
- Venlafaxine Improves the Cognitive Impairment and Depression-Like Behaviors in a Cuprizone Mouse Model by Alleviating Demyelination and Neuroinflammation in the Brain
- (2019) Yanbo Zhang et al. Frontiers in Pharmacology
- Huperzine-A, a versatile herb, for the treatment of Alzheimer’s disease
- (2019) Shih-Jen Tsai Journal of the Chinese Medical Association
- Myelin in the Central Nervous System: Structure, Function, and Pathology
- (2019) Christine Stadelmann et al. PHYSIOLOGICAL REVIEWS
- Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture
- (2019) Koneczny et al. Cells
- Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
- (2019) Simon Faissner et al. NATURE REVIEWS DRUG DISCOVERY
- A silent agonist of α7 nicotinic acetylcholine receptors modulates inflammation ex vivo and attenuates EAE
- (2019) Jean-Rémi Godin et al. BRAIN BEHAVIOR AND IMMUNITY
- Behavioural phenotypes in the cuprizone model of central nervous system demyelination
- (2019) Monokesh K. Sen et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Attenuation in Nicotinic Acetylcholine Receptor α9 and α10 Subunit Double Knock-Out Mice of Experimental Autoimmune Encephalomyelitis
- (2019) Qiang Liu et al. Biomolecules
- Myelin Plasticity and Nervous System Function
- (2018) Michelle Monje Annual Review of Neuroscience
- Multiple Sclerosis
- (2018) Hernan Nicolas Lemus et al. NEUROLOGIC CLINICS
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease
- (2018) Amara Gul et al. Journal of the Chinese Medical Association
- Nicotinic Acetylcholine Receptor Agonists for the Treatment of Alzheimer’s Dementia: An Update
- (2018) Justin L Hoskin et al. NICOTINE & TOBACCO RESEARCH
- Arecoline attenuates memory impairment and demyelination in a cuprizone-induced mouse model of schizophrenia
- (2018) Zhizhong Xu et al. NEUROREPORT
- Administration of Huperzine A exerts antidepressant-like activity in a rat model of post-stroke depression
- (2017) Yuan Du et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Huperzine A Inhibits CCL2 Production in Experimental Autoimmune Encephalomyelitis Mice and in Cultured Astrocyte
- (2017) G.X. Tian et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- A mouse model for testing remyelinating therapies
- (2016) C. Brian Bai et al. EXPERIMENTAL NEUROLOGY
- JapaneseHuperzia serrataextract and the constituent, huperzine A, ameliorate the scopolamine-induced cognitive impairment in mice
- (2015) Takuya Ohba et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Huperzine A prophylaxis against pentylenetetrazole-induced seizures in rats is associated with increased cortical inhibition
- (2015) R. Gersner et al. EPILEPSY RESEARCH
- Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII)
- (2015) Meir Bialer et al. EPILEPSY RESEARCH
- Heathcock-Inspired Strategies for the Synthesis of Fawcettimine-TypeLycopodiumAlkaloids
- (2013) Rebecca A. Murphy et al. CHEMISTRY-A EUROPEAN JOURNAL
- The anti-inflamm-aging and hepatoprotective effects of huperzine A in d-galactose-treated rats
- (2013) Qingwei Ruan et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Huperzine A for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2013) Guoyan Yang et al. PLoS One
- Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice
- (2012) Jun Wang et al. EXPERIMENTAL NEUROLOGY
- 6 2* and 4 2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
- (2011) M. Quik et al. PHARMACOLOGICAL REVIEWS
- Traditional Chinese medicines and Alzheimer’s disease
- (2011) Tzong-Yuan Wu et al. Taiwanese Journal of Obstetrics & Gynecology
- Role of Huperzine a in the Treatment of Alzheimer's Disease
- (2009) Alicia R Desilets et al. ANNALS OF PHARMACOTHERAPY
- Cerebellar Cortical Demyelination in the Murine Cuprizone Model
- (2009) Thomas Skripuletz et al. BRAIN PATHOLOGY
- Regional differences between grey and white matter in cuprizone induced demyelination
- (2009) Viktoria Gudi et al. BRAIN RESEARCH
- [+]-Huperzine A treatment protects against N-methyl-d-aspartate-induced seizure/status epilepticus in rats
- (2008) Brian R. Coleman et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Demyelination of the hippocampus is prominent in the cuprizone model
- (2008) Paraskevi N. Koutsoudaki et al. NEUROSCIENCE LETTERS
- Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse
- (2008) Y ZHANG et al. SCHIZOPHRENIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started